SEC Form 4 · accession 0001209191-18-032580
Eloxx Pharmaceuticals, Inc. · ELOX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Ward
Officer — Chief Executive Officer · Director
Period of report
May 22, 2018
Accepted (ET)
May 23, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001035354
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2018 | P | 5,000 | $14.34 | A | 15,000 | D |
Table II — derivative securities
No Table II lines on this filing.